Supporting this notion, our data demonstrate that SRSF9 acts as a pro‐hypertrophy protein, and knockdown of SRSF9 rescues TAC or Mettl1‐induced cardiac hypertrophy and remodeling. The gene discussed is SRSF9; the disease is cardiac hypertrophy.